Presentation on Moxikind-CV by Nitin Mishra

mnitin14 81 views 20 slides May 13, 2024
Slide 1
Slide 1 of 20
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20

About This Presentation

Made by Nitin Mishra
Mail id :- [email protected]
LinkedIn :- https://www.linkedin.com/in/nitin-r-mishra-4b3a701b1


Slide Content

“ M oxikind CV :- A Comprehensive Overview” Presented by :- Nitin Mishra Date :-

About Bacterial Infection Introduction to Moxikind CV Mechanism of Action Indications Available strength & Price Dosage and Administration Table of contents Efficacy, Safety & Guidelines Knowing Competitors Market Analysis SWOT Analysis Strategic Objectives Q & A Session

Bacterial Infection Bacteria are living things with only a single cell that can reproduce quickly. These bacteria often enter the body through avenues such as the mouth, nose, eyes, or openings in the skin. The bacteria may target specific organs, tissues, or systems, causing disruptions in your normal bodily functions 7.7 million deaths around the world were found linked to bacterial infection. That is 13.6%, or 1 in 8, of all global deaths.

Common Bacterial Infections Staphylococcus Aureus Streptococcus Pyogenes Streptococcus Pneumoniae Neisseria Gonorrhoeae Helicobacter Pylori Salmonella

Classification of Bacteria

Symptoms of Bacterial Infection General : Fever Chills Fatigue Localised : Swelling Pain Organ Dysfunction Redness

In troduction to Moxikind Cv Moxikind CV typically contains a combination of Amoxicillin and Clavulanic Acid. Amoxicillin is a penicillin-type antibiotic that works by stopping the growth of bacteria, while Clavulanic Acid helps prevent bacteria from becoming resistant to Amoxicillin. Moxikind CV is a broad-spectrum antibiotic medication primarily used to treat bacterial infections in various parts of the body. It belongs to the class of antibiotics known as cephalosporins, which are widely prescribed for their efficacy against a wide range of bacteria.

Mechanism of Action GRAM +ve Bacteria GRAM –ve Bacteria

Indication Moxikind CV is indicated for the treatment of various bacterial infections, including :- Ear, nose, and throat infections Skin and soft tissue infections Urinary tract infections Dental infections

Available Strength & Price Adults Moxikind-CV – (Tablets)- Amoxycillin 875 mg + Clavulanic acid 125 mg (MRP – 36.99/Tab) Moxikind-CV – (Tablets)- Amoxycillin 500 mg + Clavulanic acid 125 mg (MRP – 19.18/Tab) Moxikind-CV – (Tablets)- Amoxycillin 250 mg + Clavulanic acid 125 mg (MRP – 16.99/Tab) Paediatric Moxikind-CV – (Dry Syrup)- Amoxycillin 200 mg + Clavulanic acid 28.5mg /5ml (MRP – 67.53) Moxikind-CV – (Forte Dry Syrup)- Amoxycillin 400 mg + Clavulanic acid 57 mg/ 5 ml (MRP – 159.50) Moxikind-CV – (Drops)- Amoxycillin 80 mg + Clavulanic acid 11.4 mg/ ml (MRP – 87.19) Moxikind-CV – (Kids Tablet)- Amoxycillin 200 mg + Clavulanic acid 28.5 mg (MRP – 9.9/Tab)

Dosage and Administration The dosage of Moxikind CV varies depending on the severity of the infection and the patient's age and weight. Adult The usual adult dose is one 625-mg tablet of Moxikind-CV every 12 hours or one 375-mg tablet in every 8 hours. For more severe infections and infections of the Respiratory tract, the dose should be one 875-mg tablet every 12 hours or one 625-mg tablet every 8 hours. Pediatric 2-6 years (13-21 Kg) -5ml BID, 7-12 years (22-40 Kg) – 10ml BID Dosage of Moxikind CV Forte (DS) 2-6 years (13-21 kg) 7-12 years (22-40 kg) Mild to moderate infection 2.5ml BID 5ml BID Severe infection 5ml BID 10ml BID

Efficacy, Safety & Guidelines Efficacy & Guidelines Manufactured through EPA technology :- Ensuring less GI effect (abdominal pain & Diarrhea) & thus give a desired result Higher Bioavailability Rate & Faster Dissolution. Lesser Resistance Potential Guidelines like AAP & Nelson textbook of paediatrics recommendation. Recommendation of ICMR guidelines in Oro dental Infection. WHO Categorized Amoxycillin and Clavulanic acid in Model list of medicines which has Low-Resistance Potential

Moxikind CV is generally well-tolerated, but like any medication, it may cause side effects in some individuals. Like Diarrhea, abdominal pain, Mucocutaneous candidiasis, Nausea, vomiting Contraindication :- Hypersensitivity to Penicillin’s. Precaution :- Renal and hepatic impairment. Restrictions :- Restricted to individuals with severe hepatic impairment, pregnant and lactating.

Knowing Competitors There are several brands available in the market Brands like :- Augmentin 625mg/ Augment ES (GSK) Clavam 625mg/ES (Alkem) Moxiclav 625mg/ES (Sun) Sensiclav 625mg (Macleods Pharma) MPX CV 625 (Hetero)

Market Analysis

Performance of top fastest growing market in IPM-JAN’24 Sr No. Metro Values’Cr (MAT 23) Gwth % (MAT 23) Values’Cr (MAT 24) Gwth % (MAT 24) 1 AGRA 1314.2 9.4% 1557.3 18.5% 2 BHOPAL 741.7 7.7% 876 18.1% 3 PUNE 2401.5 4.5% 2804.6 16.8% 4 NASHIK 706.7 -11.5% 819.9 16.0% 5 AHMEDABAD 2069.1 3.8% 2393.2 15.7% Agra, Bhopal, Pune, Nashik and Ahmedabad were the fastest growing markets among the top Metros like Delhi, Mumbai and Calcutta as per the IQVIA Data for MAT Jan’24.

S W O T Economical Price Established brand name Distribution Network Large sales team Less focus speciality Product Development Market development Private Practising Dr. Brand quality Generic Product In-direct Competitors Replacing with alternative

Strategic Objectives Driving Campaign Doing RTM KOL Engagement Targeted Marketing (Speciality Wise) Generating Feedback Educating Chemist
Tags